# Prime Medicine, Inc.: Form 8-K, filed Mar 3, 2026

- Company: [Prime Medicine, Inc.](/companies/prme.md) (CIK 1894562)
- Form: 8-K
- Filed: 2026-03-03
- Accepted by EDGAR: Mar 3, 2026, 08:02 ET
- Period: 2026-03-03
- Accession: 0001628280-26-013565
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1894562/000162828026013565/prme-20260303.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1894562/000162828026013565/

## Items reported

- Item 2.02: Results of operations
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1894562/000162828026013565/prme-20260303.htm

Filed Mar 3, 2026.
Source: SEC EDGAR, the filing index for accession 0001628280-26-013565. Last ingested by Listed: Oct 24, 2026, 15:06 ET. No prices; not investment advice.